Secnidazole: a treatment for trichomoniasis in adolescents and adults
Sign Up to like & getrecommendations! Published in 2022 at "Expert Review of Anti-infective Therapy"
DOI: 10.1080/14787210.2022.2080656
Abstract: ABSTRACT Introduction Single-dose 2-g oral secnidazole (SEC), newly approved by the U.S. Food and Drug administration (FDA) for treatment of trichomoniasis, is a potent 5-nitroimidazole with selective toxicity against various micro-organisms. It has been used… read more here.
Keywords: trichomoniasis; secnidazole treatment; trichomoniasis adolescents; treatment trichomoniasis ... See more keywords